1.17
price down icon8.95%   -0.115
after-market アフターアワーズ: 1.17
loading
前日終値:
$1.285
開ける:
$1.25
24時間の取引高:
1.27M
Relative Volume:
0.74
時価総額:
$84.02M
収益:
-
当期純損益:
$-292.19M
株価収益率:
-0.2577
EPS:
-4.54
ネットキャッシュフロー:
$-208.41M
1週間 パフォーマンス:
-35.36%
1か月 パフォーマンス:
-37.43%
6か月 パフォーマンス:
-65.28%
1年 パフォーマンス:
-92.36%
1日の値動き範囲:
Value
$1.13
$1.28
1週間の範囲:
Value
$1.13
$1.76
52週間の値動き範囲:
Value
$1.13
$15.79

Zentalis Pharmaceuticals Inc Stock (ZNTL) Company Profile

Name
名前
Zentalis Pharmaceuticals Inc
Name
セクター
Healthcare (1162)
Name
電話
(858) 263-4333
Name
住所
10275 SCIENCE CENTER DRIVE, SAN DIEGO, NY
Name
職員
166
Name
Twitter
@ZentalisP
Name
次回の収益日
2025-03-26
Name
最新のSEC提出書
Name
ZNTL's Discussions on Twitter

ZNTL を他の銘柄と比較する

株式 価格 時価総額 収益 当期純利益 現金流量 EPS
Biotechnology icon
ZNTL
Zentalis Pharmaceuticals Inc
1.17 84.02M 0 -292.19M -208.41M -4.54
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
474.62 121.88B 11.02B -535.60M -978.00M -2.20
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
573.45 62.69B 14.20B 4.41B 3.54B 38.28
Biotechnology icon
ARGX
Argen X Se Adr
555.11 33.86B 2.19B 833.04M -1.28B 12.71
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
235.74 30.51B 2.25B -278.16M -42.59M -2.17
Biotechnology icon
ONC
Beigene Ltd Adr
238.51 25.69B 3.81B -644.79M -669.77M -6.24

Zentalis Pharmaceuticals Inc Stock (ZNTL) Upgrades & Downgrades

日付 アクション アナリスト 評価の変更
2024-08-12 アップグレード Wedbush Underperform → Neutral
2024-06-20 ダウングレード UBS Buy → Neutral
2024-06-18 ダウングレード Jefferies Buy → Hold
2024-06-18 ダウングレード Morgan Stanley Overweight → Equal-Weight
2024-06-18 ダウングレード Wedbush Neutral → Underperform
2024-06-18 ダウングレード Wells Fargo Overweight → Equal Weight
2023-11-08 ダウングレード Wedbush Outperform → Neutral
2023-11-07 ダウングレード Leerink Partners Outperform → Market Perform
2022-07-12 開始されました Cowen Outperform
2022-04-06 開始されました Wells Fargo Overweight
2021-10-07 再開されました Jefferies Buy
2021-09-30 開始されました Stifel Buy
2021-09-29 開始されました Oppenheimer Outperform
2021-05-21 開始されました UBS Buy
2021-01-20 開始されました Wedbush Outperform
2020-09-29 開始されました Cantor Fitzgerald Overweight
2020-08-27 開始されました H.C. Wainwright Buy
2020-04-28 開始されました Guggenheim Buy
2020-04-28 開始されました Jefferies Buy
2020-04-28 開始されました Morgan Stanley Overweight
2020-04-28 開始されました SVB Leerink Outperform
すべてを表示

Zentalis Pharmaceuticals Inc (ZNTL) 最新ニュース

pulisher
Apr 03, 2025

Zentalis Pharmaceuticals, Inc. (NASDAQ:ZNTL) Given Average Rating of “Hold” by Brokerages - Defense World

Apr 03, 2025
pulisher
Apr 01, 2025

Zentalis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4) - MarketScreener

Apr 01, 2025
pulisher
Apr 01, 2025

Zentalis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewswire

Apr 01, 2025
pulisher
Apr 01, 2025

Zentalis Strengthens Team with $194,600 in Equity Incentives - Stock Titan

Apr 01, 2025
pulisher
Apr 01, 2025

Virtu Financial LLC Buys Shares of 24,973 Zentalis Pharmaceuticals, Inc. (NASDAQ:ZNTL) - Defense World

Apr 01, 2025
pulisher
Apr 01, 2025

Leerink Partnrs Issues Pessimistic Outlook for ZNTL Earnings - Defense World

Apr 01, 2025
pulisher
Mar 31, 2025

What is HC Wainwright’s Forecast for ZNTL Q1 Earnings? - Defense World

Mar 31, 2025
pulisher
Mar 31, 2025

Leerink Partnrs Has Pessimistic Outlook of ZNTL Q1 Earnings - Defense World

Mar 31, 2025
pulisher
Mar 30, 2025

Zentalis Pharmaceuticals, Inc. (NASDAQ:ZNTL) Position Lifted by Charles Schwab Investment Management Inc. - Defense World

Mar 30, 2025
pulisher
Mar 30, 2025

Wedbush Reiterates Neutral Rating for Zentalis Pharmaceuticals (NASDAQ:ZNTL) - Defense World

Mar 30, 2025
pulisher
Mar 28, 2025

Zentalis Pharmaceuticals: Hold Rating Amid Clinical Progress and Financial Uncertainty - TipRanks

Mar 28, 2025
pulisher
Mar 28, 2025

Bank of New York Mellon Corp Sells 10,375 Shares of Zentalis Pharmaceuticals, Inc. (NASDAQ:ZNTL) - Defense World

Mar 28, 2025
pulisher
Mar 28, 2025

Zentalis Pharmaceuticals (NASDAQ:ZNTL) Receives “Buy” Rating from HC Wainwright - Defense World

Mar 28, 2025
pulisher
Mar 28, 2025

Zentalis Pharmaceuticals Reports Progress and Financials - TipRanks

Mar 28, 2025
pulisher
Mar 27, 2025

Stifel maintains Buy on Zentalis stock with $9 target By Investing.com - Investing.com Canada

Mar 27, 2025
pulisher
Mar 27, 2025

H.C. Wainwright sets $10 target for Zentalis shares, maintains Buy By Investing.com - Investing.com Canada

Mar 27, 2025
pulisher
Mar 26, 2025

Zentalis Pharmaceuticals Inc Reports Annual EPS of -$2.33, Excee - GuruFocus

Mar 26, 2025
pulisher
Mar 26, 2025

Zentalis Pharmaceuticals Reports Full Year 2024 Financial Results and Operational Updates - GlobeNewswire

Mar 26, 2025
pulisher
Mar 26, 2025

Zentalis Pharmaceuticals Inc reports results for the quarter ended December 31Earnings Summary - TradingView

Mar 26, 2025
pulisher
Mar 26, 2025

Zentalis Pharmaceuticals Inc Files For Mixed Shelf Of Up To $250 MillionSEC Filing - Marketscreener.com

Mar 26, 2025
pulisher
Mar 26, 2025

Zentalis Breakthrough: 35% Response Rate in Ovarian Cancer Trial Wins FDA Fast Track - Stock Titan

Mar 26, 2025
pulisher
Mar 25, 2025

Zentalis Pharmaceuticals to Present Multiple Posters at the - GlobeNewswire

Mar 25, 2025
pulisher
Mar 25, 2025

Major Cancer Breakthrough: Zentalis Reveals New Azenosertib Data Across Multiple Tumor Types - Stock Titan

Mar 25, 2025
pulisher
Mar 21, 2025

Zentalis Pharmaceuticals Inc expected to post a loss of 71 cents a shareEarnings Preview - TradingView

Mar 21, 2025
pulisher
Mar 20, 2025

Zentalis pharmaceuticals director Luke Walker buys $24,966 in stock - MSN

Mar 20, 2025
pulisher
Mar 19, 2025

Zentalis Pharmaceuticals (NASDAQ:ZNTL) Earns Buy Rating from HC Wainwright - The AM Reporter

Mar 19, 2025
pulisher
Mar 17, 2025

H.C. Wainwright maintains $10 target on Zentalis stock By Investing.com - Investing.com Canada

Mar 17, 2025
pulisher
Mar 17, 2025

Zentalis Highlights Promising Azenosertib Data at SGO 2025 - TipRanks

Mar 17, 2025
pulisher
Mar 15, 2025

Zentalis Pharmaceuticals Presents Updated Clinical Data at - GlobeNewswire

Mar 15, 2025
pulisher
Mar 15, 2025

Zentalis Pharmaceuticals Presents Updated Clinical Data at the Society of Gynecologic Oncology 2025 Annual Meeting on Women's Cancer - MarketScreener

Mar 15, 2025
pulisher
Mar 15, 2025

Zentalis Announces Updated Clinical Data From Part 1b Of DENALI Trial Of Azenosertib In PROC - Nasdaq

Mar 15, 2025
pulisher
Mar 15, 2025

Zentalis Pharmaceuticals Presents Updated Clinical Data at the Society of Gynecologic Oncology 2025 Annual Meeting on Women’s Cancer - TradingView

Mar 15, 2025
pulisher
Mar 11, 2025

Zentalis Pharmaceuticals Inc (NASDAQ: ZNTL) Has Been Trading Down. What Are The Prospects For The Future? - stocksregister.com

Mar 11, 2025
pulisher
Mar 09, 2025

Zentalis Pharmaceuticals, Inc. (NASDAQ:ZNTL) Receives Average Rating of “Hold” from Brokerages - Defense World

Mar 09, 2025
pulisher
Mar 08, 2025

ZNTL SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces an Investigation into Zentalis Pharmaceuticals, Inc. and Encourages Investors to Contact the Firm! - ACCESS Newswire

Mar 08, 2025
pulisher
Mar 03, 2025

How Zentalis Is Attracting Talent: Inside Their Latest Employee Compensation Package - StockTitan

Mar 03, 2025
pulisher
Mar 03, 2025

Zentalis Pharmaceuticals Announces Multiple Data - GlobeNewswire

Mar 03, 2025
pulisher
Mar 03, 2025

Zentalis Pharmaceuticals Announces Multiple Data Presentations at Society of Gynecologic Oncology 2025 Annual Meeting on Women's Cancer - The Manila Times

Mar 03, 2025
pulisher
Mar 03, 2025

Zentalis Pharmaceuticals Announces Multiple Data Presentations at Society of Gynecologic Oncology 2025 Annual Meeting on Women’s Cancer - Yahoo Finance

Mar 03, 2025
pulisher
Mar 03, 2025

Can Zentalis's Azenosertib Change Treatment Landscape for Resistant Ovarian Cancer? - Stock Titan

Mar 03, 2025
pulisher
Feb 27, 2025

A company insider recently bought 20,000 shares of Zentalis Pharmaceuticals Inc [ZNTL]. Should You Buy? - Knox Daily

Feb 27, 2025
pulisher
Feb 25, 2025

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Zentalis Pharmaceuticals, Inc.ZNTL - PR Newswire

Feb 25, 2025
pulisher
Feb 24, 2025

Zentalis Pharmaceuticals to Participate in Upcoming Investor Conferences - GlobeNewswire

Feb 24, 2025
pulisher
Feb 24, 2025

Can Zentalis' Novel Cancer Drug Pipeline Impress at Two Elite Healthcare Conferences? - StockTitan

Feb 24, 2025
pulisher
Feb 23, 2025

Zentalis Pharmaceuticals (ZNTL) Projected to Post Quarterly Earnings on Tuesday - The AM Reporter

Feb 23, 2025
pulisher
Feb 22, 2025

Zentalis stock price target cut to $10 by H.C. Wainwright - MSN

Feb 22, 2025
pulisher
Feb 22, 2025

Zentalis pharmaceuticals officer sells $24,590 in stock - MSN

Feb 22, 2025
pulisher
Feb 21, 2025

Zentalis Pharmaceuticals (ZNTL): Among Cheapest Stocks Insiders Are Buying Recently - Yahoo Finance

Feb 21, 2025

Zentalis Pharmaceuticals Inc (ZNTL) 財務データ

収益

loading

当期純利益

loading

現金流量

loading

EPS

loading
$60.58
price down icon 3.01%
$69.18
price down icon 5.66%
$17.36
price down icon 8.20%
$31.11
price down icon 2.14%
$88.05
price down icon 4.30%
biotechnology ONC
$238.51
price down icon 9.76%
大文字化:     |  ボリューム (24 時間):